444 related articles for article (PubMed ID: 17910086)
1. Genetic mechanisms involved in the phenotype of Down syndrome.
Patterson D
Ment Retard Dev Disabil Res Rev; 2007; 13(3):199-206. PubMed ID: 17910086
[TBL] [Abstract][Full Text] [Related]
2. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 21 and down syndrome: from genomics to pathophysiology.
Antonarakis SE; Lyle R; Dermitzakis ET; Reymond A; Deutsch S
Nat Rev Genet; 2004 Oct; 5(10):725-38. PubMed ID: 15510164
[TBL] [Abstract][Full Text] [Related]
4. Using mouse models to explore genotype-phenotype relationship in Down syndrome.
Salehi A; Faizi M; Belichenko PV; Mobley WC
Ment Retard Dev Disabil Res Rev; 2007; 13(3):207-14. PubMed ID: 17910089
[TBL] [Abstract][Full Text] [Related]
5. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I).
Cheon MS; Kim SH; Yaspo ML; Blasi F; Aoki Y; Melen K; Lubec G
Amino Acids; 2003; 24(1-2):111-7. PubMed ID: 12624742
[TBL] [Abstract][Full Text] [Related]
6. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).
Cheon MS; Kim SH; Ovod V; Kopitar Jerala N; Morgan JI; Hatefi Y; Ijuin T; Takenawa T; Lubec G
Amino Acids; 2003; 24(1-2):127-34. PubMed ID: 12624744
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling in the adult Down syndrome brain.
Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
[TBL] [Abstract][Full Text] [Related]
8. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
Rachidi M; Lopes C
Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
[TBL] [Abstract][Full Text] [Related]
9. Maternal balanced translocation (4;21) leading to an offspring with partial duplication of 4q and 21q without phenotypic manifestations of Down syndrome.
El-Ruby M; Hemly NA; Zaki MS
Genet Couns; 2007; 18(2):217-26. PubMed ID: 17710874
[TBL] [Abstract][Full Text] [Related]
10. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
Rachidi M; Lopes C
Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
[TBL] [Abstract][Full Text] [Related]
11. Down syndrome mouse models are looking up.
Reeves RH
Trends Mol Med; 2006 Jun; 12(6):237-40. PubMed ID: 16677859
[TBL] [Abstract][Full Text] [Related]
12. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
13. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II).
Cheon MS; Bajo M; Kim SH; Claudio JO; Stewart AK; Patterson D; Kruger WD; Kondoh H; Lubec G
Amino Acids; 2003; 24(1-2):119-25. PubMed ID: 12624743
[TBL] [Abstract][Full Text] [Related]
14. The DNA sequence of human chromosome 21.
Hattori M; Fujiyama A; Taylor TD; Watanabe H; Yada T; Park HS; Toyoda A; Ishii K; Totoki Y; Choi DK; Groner Y; Soeda E; Ohki M; Takagi T; Sakaki Y; Taudien S; Blechschmidt K; Polley A; Menzel U; Delabar J; Kumpf K; Lehmann R; Patterson D; Reichwald K; Rump A; Schillhabel M; Schudy A; Zimmermann W; Rosenthal A; Kudoh J; Schibuya K; Kawasaki K; Asakawa S; Shintani A; Sasaki T; Nagamine K; Mitsuyama S; Antonarakis SE; Minoshima S; Shimizu N; Nordsiek G; Hornischer K; Brant P; Scharfe M; Schon O; Desario A; Reichelt J; Kauer G; Blocker H; Ramser J; Beck A; Klages S; Hennig S; Riesselmann L; Dagand E; Haaf T; Wehrmeyer S; Borzym K; Gardiner K; Nizetic D; Francis F; Lehrach H; Reinhardt R; Yaspo ML;
Nature; 2000 May; 405(6784):311-9. PubMed ID: 10830953
[TBL] [Abstract][Full Text] [Related]
15. Trisomy of chromosome 21 in leukemogenesis.
Izraeli S; Rainis L; Hertzberg L; Smooha G; Birger Y
Blood Cells Mol Dis; 2007; 39(2):156-9. PubMed ID: 17532652
[TBL] [Abstract][Full Text] [Related]
16. Gene-dosage effect on chromosome 21 transcriptome in trisomy 21: implication in Down syndrome cognitive disorders.
Kahlem P
Behav Genet; 2006 May; 36(3):416-28. PubMed ID: 16557362
[TBL] [Abstract][Full Text] [Related]
17. Human chromosome 21/Down syndrome gene function and pathway database.
Nikolaienko O; Nguyen C; Crinc LS; Cios KJ; Gardiner K
Gene; 2005 Dec; 364():90-8. PubMed ID: 16310977
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of chromosome 21 in a patient with a phenotype of Down syndrome and apparently normal karyotype.
Ahlbom BE; Goetz P; Korenberg JR; Pettersson U; Seemanova E; Wadelius C; Zech L; Annerén G
Am J Med Genet; 1996 Jun; 63(4):566-72. PubMed ID: 8826436
[TBL] [Abstract][Full Text] [Related]
19. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.
Pritchard MA; Kola I
J Neural Transm Suppl; 1999; 57():293-303. PubMed ID: 10666684
[TBL] [Abstract][Full Text] [Related]
20. A patient with partial trisomy 21 and 7q deletion expresses mild Down syndrome phenotype.
Papoulidis I; Papageorgiou E; Siomou E; Oikonomidou E; Thomaidis L; Vetro A; Zuffardi O; Liehr T; Manolakos E; Vassilis P
Gene; 2014 Feb; 536(2):441-3. PubMed ID: 24334122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
